The inflammatory response to bacteria and bacterial products, such as lipopolysaccharides (LPSs), is mediated by a variety of secreted factors, but cytotoxic effects of LPS have been ascribed to the tumor necrosis factor alpha (TNF-a) activity. TNF-a is probably the most pleiotropic cytokine and, given the deleterious effects to the host of this factor, it has been postulated that its expression must be tightly regulated. Our laboratory has recently isolated, cloned and characterized a novel human transcription factor named LITAF or LPS-induced TNF-alpha factor. The present study reports the isolation, cloning and characterization of the mouse LITAF cDNA. Chromosomal localization revealed that mouse LITAF mapped to mouse chromosome 16, in a region highly homologous with the area on which human LITAF was previously located. Northern blot analysis shows that mouse LITAF is already expressed at embryonic day 7 of development, and is highly expressed in adult liver, heart and kidney. Moreover, upon LPS stimulation, we show that: (i) LITAF expression is increased in a mouse monocyte/macrophage cell line; and (ii) TNF-a expression is reduced in ES cell-derived macrophages lacking one copy of LITAF gene. Taken together, these results highlight the important role of LITAF in the regulation of TNF-a gene expression and suggest a potential role of LITAF in mouse organogenesis.
INTRODUCTION
The innate immune response to bacteria and bacterial products, such as lipopolysaccharides (LPSs), is characterized by the rapid release of biological compounds, including monokines and cytokines, which help the host to eliminate pathogens efficiently. However, dysregulated cytokine expression has been linked to inflammatory diseases in both acute (e.g. septic shock or multiple organ failure syndrome) and chronic (e.g. rheumatoid arthritis, Crohn's disease or periodontitis) settings. 1, 2 Although the inflammatory response is mediated by a variety of secreted factors, the cytotoxic effects of LPS have been ascribed to tumor necrosis factor-a (TNF-a) activity. [3] [4] [5] TNF-a effects can be both beneficial and detrimental to the host. [6] [7] [8] The pleiotropic effects of TNF-a are dose-dependent. 9 Hence, the perceived need to control TNF-a production has raised interest into understanding of the mechanisms that modulate TNF-a gene expression.
The human TNF-a promoter contains motifs that resemble NF-kB-binding sites; however, controversy exists as to the involvement of NF-kB in TNF-a gene regulation. Our previous studies pertaining to macrophage response to LPS identified a DNA sequence domain of 64 bp in the human TNF-a promoter, located from -550 to -487, and containing no potential NF-kB-binding sites. 10 Using this fragment as probe, our laboratory has isolated, cloned and characterized a novel transcription factor named LITAF for LPSinduced TNF-alpha factor, as its expression results from LPS stimulation of the macrophage cell line THP-1. Moreover, inhibition of LITAF mRNA translation using antisense RNA in THP-1 cells resulted in a dramatic reduction of TNF-a transcripts after LPS exposure. 11 Taken together, our findings suggest that this factor plays an important role in human TNF-a gene activation.
By using the human cDNA as probe in the screening of a mouse BAC 129/Svj library, we have isolated two genomic clones corresponding to the LITAF gene. By using exon 2 to screen a mouse heart cDNA library, we have isolated, cloned and characterized the mouse LITAF full length cDNA (1.1 kb) with a deduced amino acid sequence of the ORF encoding 161 amino acids. Chromosomal localization using fluorescence in situ hybridization (FISH) revealed that mouse LITAF mapped to chromosome 16 at the Robertsonian translocation Rb (2;16). We show by Northern blot analysis that mouse LITAF is already expressed at embryonic day 7. In adult tissues, the gene is predominantly expressed in heart, liver and kidney. Moreover, upon LPS stimulation, we show: (i) that LITAF expression is increased in a mouse monocyte/macrophage cell line; and (ii) that in ES cell-derived macrophages, the absence of one copy of LITAF gene leads to a reduction of TNF-a expression.
MATERIALS AND METHODS

Isolation of the mouse LITAF gene
The human LITAF cDNA was used to design PCR primers for screening a mouse BAC 129/Svj library. Two positive BAC clones were obtained of approximately 120 kb. A 26 kb contiguous mapping for the mouse LITAF was generated and characterized. Exon 2 was used to design oligoprobes to screen a mouse heart Uni-Zap™ XR cDNA library (Stratagene). Nine positive clones containing 0.8-1.1 kb inserts were obtained after screening 5 x 10 5 colonies. The longest mouse LITAF cDNA (1.1 kb) was chosen for complete sequencing following the dideoxynucleotide chain-termination method using a 373A sequencer (Applied Biosystems).
Fluorescence in situ hybridization (FISH) on murine chromosomes
Metaphase spreads were prepared from WMP male and female mice, in which all the autosomes except chromosome 19 were in the form of metacentric Robertsonian translocations. 12 Concanavalin A-stimulated lymphocytes were cultured at 37°C for 72 h, with 5-bromodeoxyuridine added for the final 6 h of culture (60 mg/ml of medium) to ensure a chromosomal R-banding of good quality.
An 8 kb mouse LITAF genomic clone was biotinylated by random priming with biotin-[ 14 C]-dUTP, as outlined by the Invitrogen protocol (Invitrogen). Hybridization to chromosome spreads was performed with a standard protocol. 13 The biotin-labeled DNA was mixed with hybridization solution at a final concentration of 10 mg/ml and used at 200 ng per slide. Before hybridization, the labeled probe was annealed for 45 min at 37°C, with a 250-fold excess of murine Cot-1 DNA (Invitrogen) in order to compete the aspecific repetitive sequences.
The hybridized probe was detected by means of fluorescein isothiocyanate-conjugated avidin (Vector Laboratories). Chromosomes were counterstained and R-banded with propidium iodide diluted in an antifading solution pH 11.0.
Northern blot analysis
Total RNA was extracted from RAW 264.7 cells using RNA STAT-60 (Tel-Test) following the manufacturer's instructions. After dissolution in DEPC-treated water, 10 mg of total RNA was size fractionated on a denaturing formaldehyde-agarose gel (1%) and transferred against 10x SSC onto an Hybond N + membrane (Amersham) using the vacuum blotter from BioRad. For LITAF expression pattern determination, Northern blot filters with 3 mg of total RNA from different mouse developmental stages and several adult mouse tissues were obtained from Clontech. After 30 min prehybridization at 68°C, the filters were hybridized at 68°C for 1 h with the coding region of the mouse LITAF cDNA labeled by random priming with [a-32 P]-dCTP (3000 Ci/mmol; NEN Research Products, Boston, MA, USA) in ExpressHyb hybridization solution (Clontech). The filters were washed 3 times at room temperature in 2x SSC/0.05% SDS, twice in 0.1x SSC/0.1% SDS at 55°C and then autoradiographed with Biomax MR film (Kodak).
The G3PDH probe (Clontech) was used as a control for quantification. The amount of LITAF expression was quantified using the Kodak Digital Science 1D software (Kodak).
Reverse transcription -polymerase chain reaction
Total RNA (400 ng) from adult liver, testis, RAW 264.7 cells and macrophage-ES cells was used to perform cDNA synthesis using Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT, Invitrogen), in the presence of 20 mg 3¢ antisense gene-specific primer in conditions described by the manufacturer (Invitrogen). Briefly, the RNA was reverse-transcribed for 1 h at 37°C in the presence of 50 mM Tris HCl, pH 8.3, 75 mM KCl, 10 mM DTT, 3 mM MgCl 2 , 0.5 mM of each dNTP and 200 units of M-MLV RT in a total volume of 20 ml.
A 2 ml aliquot of reverse transcriptase reaction mixture served for PCR amplification in the presence of 0.5 mM of each gene specific primer (3¢ and 5¢). The reaction was performed in a total volume of 20 ml with 1x PCR buffer without Mg (Invitrogen), 0.2 mM of each dNTP, 1.5 mM MgCl 2 and 0.5 units of Taq DNA polymerase (Invitrogen). The thermocycling profile of the PCR amplification consists in denaturation at 94°C for 5 min, then 30 cycles of denaturation at 94°C for 1 min, primer annealing at 55°C for 1 min, and polymerisation at 72°C for 10 min and then elongation for 10 min at 72°C. Aliquots of 15 ml of each PCR reaction were loaded on 1.2% agarose gel for electrophoresis, stained with ethidium bromide and transferred onto an Hybond N + membrane (Amersham). Specificity of the RT-PCR products was determined by hybridization of the filter at 68°C for 1 h with the coding region of the mouse LITAF cDNA labeled by random priming with [a-32 P]-dCTP (3000 Ci/mmol; NEN Research Products, Boston, MA, USA). Hybridization was performed in ExpressHyb hybridization solution (Clontech). Filters were then treated as described under Northern blot analysis.
Three sets of primers were used for RT-PCR amplification on mouse LITAF cDNA transcribed from adult liver, adult testis or RAW 264.7 cells total RNA: Primer-1 for:
5¢-ATGTCGGCTCCAGGACCTTA-3¢ (located at position 32 on the mouse LITAF cDNA)
Primer-1 rev: 5¢-GAGACAGGAAGGAATGTGAGCCTT-3¢ (located at position 1092)
Primer-2 for: 5¢-CACCCAGCCTGTGCCTGTCCCCAA-3¢ (located at position 217)
Characterization of mouse LITAF and role in TNF-a regulation 17 For reverse transcription on macrophage differentiated ES cell mRNA, the following TNF-a primers: rev 3¢-CACCCCGAAGTTCAGTAGACA-5¢, for 3¢-TAG-CCAGGAGGGAGAACAGA-5 ¢ and b-actin primers: rev 5¢-CAAACATGATCTGGGTCATCTTCTC-3¢, for 5¢-GCTCGTCGTCGACAACGGCTC-3¢ were used.
Cell culture
The RAW 264.7 mouse monocyte/macrophage cell line (from ATCC) was maintained in Dulbecco's modified Eagle's medium (DMEM) with 4 mM L-glutamine, 4.5 g/l glucose, 1.5 g/l sodium bicarbonate (from ATCC) supple- mented with 10% inactivated fetal calf serum (Invitrogen). At confluency, the cells were stimulated by 100 ng/ml Escherichia coli LPS (List Biological Laboratories, Inc.) for 4 h. After stimulation, total cellular mRNA was collected using RNA STAT-60 solution (Tel-Test) according to the manufacturer's instructions. The RNA was dissolved in DEPC-treated water and subjected to Northern blot analysis.
ES cell line D3 from mouse strain 129/Svj (agouti) was used and transfected with a mouse LITAF-targeting vector as part of the generation of a LITAF-deficient animal. After antibiotic selections, ES cells were selected and confirmed to be targeted for LITAF. ES cells were cultured on irradiated embryonal fibroblast feeder layers in DMEM medium containing 15% fetal bovine serum (Hyclone Laboratories, Inc.) and 100 U penicillin/streptomycin supplemented with 0.7% leukemia inhibitory factor to maintain their undifferentiated pluripotent state. The ES cells were differentiated into macrophage lineage in the presence of 15% L929-CM (CSF-1) and 3% IL-3 as described by Moore et al. 4 The cells were stimulated with 100 ng/ml E. coli LPS (List Biological Laboratories, Inc.) for 2.5 h before RNA extraction. RNA was extracted using the Qiagen Rneasy kit according to the manufacturer's instructions. To avoid LPS contamination, all media, water and buffers were purchased from Invitrogen.
Only materials containing less than 10 pg/ml of contamination were used.
RESULTS
Cloning, sequencing and chromosomal localization of mouse LITAF
Using a human LITAF probe, we have isolated mouse genomic clones. Each genomic clone was mapped and Exon 2 was used to isolate the mouse LITAF cDNA. As shown in Figure 1 , the cDNA consist of a 31-nucleotide 5¢ non-coding region, 542-nucleotide ORF and a 613nucleotide 3¢ non-coding region that includes a poly(A) signal. The ORF encodes 161 amino acids, corresponding to a 19.7 kDa protein (GenBank accession no. AF230522). Sequence alignment between human and mouse cDNA revealed more than 80% homology (Fig. 1B) .
Using an 8-kb mouse LITAF genomic fragment as probe, FISH was performed to mouse metaphase spreads. A total of 60 metaphase cells were analyzed, and 98% of them showed specific fluorescent spots on the B1-B3 region of murine chromosome 16. This resulted in specific localization to chromosome 16 (Fig. 2) , belonging to the
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Fig. 1Bb
Robertsonian translocation Rb (2;16). The murine 16B1-B3 is homologous to the human 16p12-p13.3, in which the human LITAF was previously located. 11 
Expression pattern of LITAF gene during mouse embryonic development and in mouse adult tissues
Using the coding region of mouse LITAF cDNA as a probe, Northern blot analysis revealed two transcripts at 2.2 and 1.1 kb (Fig. 3) . During embryonic development, mouse LITAF cDNA is already expressed at day 7 and its expression drops at 11 days (Fig. 3A) . In mouse adult tissues, the gene is expressed mainly in liver and to a lesser extent in heart and kidney (Fig. 3B ). Weak expression is also observed in spleen, lung and testis.
As two bands were observed by Northern blot, we performed RT-PCR on RNA extracted from different tissues (mouse monocyte/macrophage RAW 267.4 cells, liver and testis) using three sets of primers as shown in Figure 4A . The original mouse cDNA clone was used as a control. Figure 4B illustrates data obtained for adult liver. The bands observed by RT-PCR are at the expected size for mouse LITAF cDNA. Specificity of the RT-PCR products was confirmed by Southern blot hybridization using the coding region of the LITAF gene as probe (data not shown).
LITAF induction by LPS and regulation of TNF-a expression by LITAF
Northern blot analysis of total RNA extracted from the mouse monocyte/macrophage RAW 264.7 cells showed two transcripts for the mouse LITAF gene (Fig. 5) . A 2fold increase of each transcript was observed after 4 h of E. coli LPS stimulation (Fig. 5 ). This result confirms the data obtained in human monocytes showing that LITAF expression was also increased after LPS stimulation. 11 20 Bolcato-Bellemin, Mattei, Fenton, Amar LITAF +/-ES cells and wild-type control cells cultured and differentiated into macrophage lineage 14 were exposed to LPS and analyzed by RT-PCR to determine TNF-a mRNA levels. A reduction of TNF-a mRNA levels was observed in macrophages +/-LITAF (35%) compared to wild-type cells (Fig. 6) , demonstrating that LPS-induced TNF-a gene expression is dependent, at least partially, on the presence of LITAF gene product.
DISCUSSION
The present paper reports the cloning, characterization and chromosomal localization of the mouse LITAF gene, homologue to the recently isolated human LITAF gene which was shown to control TNF-a expression. 11 The mouse LITAF gene was isolated by PCR screening of a mouse BAC 129/Svj library using primers derived from the human LITAF cDNA sequence. The structure of the gene show 4 exons: exon #2 encodes the 5¢-end of mouse LITAF and the ATG start codon; exon #3 encodes the middle portion of the LITAF gene; and exon #4 encodes the 3¢ end of the gene. No start codon exists in any frame in the last 3¢-end portion of the gene. Exon 2 of the mouse genomic clone was used to screen a heart cDNA library. Mouse LITAF was localized on chromosome 16 in a region homologous to the human 16p12-16p13.3 region, in which human LITAF was previously located. 11 Characterization of mouse LITAF and role in TNF-a regulation 21 The distribution of mouse LITAF mRNA during embryonic development shows that the gene is already expressed at 7 days, suggesting a role for LITAF in mouse organogenesis. In adult mice, the gene is predominantly expressed in liver, heart and kidney. This expression pattern parallels TNF-a tissue distribution in mice after endotoxin administration 15 and in cytomegalovirus-induced myocarditis mice treated with LPS. 16 Moreover, we have previously shown by immunofluorescence that LITAF is expressed in adult human intestine and that its protein level is increased in patients affected by Crohn's disease, an inflammatory bowel disorder (unpublished data).
Two LITAF mouse transcripts were detected by Northern blot analysis. This finding confirmed a preliminary observation made by Moriwaki et al. 20 when testing human LITAF expression in mouse RAW 264.7 cells. RT-PCR experiments using primers located within the cloned cDNA did not show any alternative splicing between the ATG and the putative poly(A) signal. Sequence analysis revealed the presence of an AATAAA motif at position 1063 followed by a putative poly(A) signal. However, we cannot exclude the presence of another polyadenylation signal located at a more 3¢ position and an alternative splicing giving rise to two transcripts for the mouse LITAF. Recent genomic structure and DNA sequence analysis of the 3¢ end of the PAX3 gene described also the existence of two previously unreported exons and a poly(A)-signal motif giving rise to different transcripts. 17 As for human LITAF, 11, 21 mouse LITAF is suspected to bind the promoter of the mouse TNF-a gene . All the public nucleotide and protein sequence databases were searched. None of the sequences in the mouse LITAF coding region were found to be similar to typical DNA-binding motifs. We did find sequences in two other regions that displayed some homology with sequences reported in the databases: several amino acid sequences were found to be similar to the Bicaudal-C gene of Drosophila melanogaster. Although the Bicaudal-C gene product contains a motif called the KH domain, which is found in many RNA and single stranded DNA-binding proteins, 18 we did not find a typical KH domain in the mouse LITAF gene.
Our experiments on mouse RAW 264.7 monocyte/ macrophage cells demonstrate that mouse LITAF expression is increased after LPS stimulation. Furthermore, mouse LITAF heterozygous ES cells (LITAF +/-cells) differentiated into the macrophage lineage and LPS-stimulated cells were found to express reduced levels of TNF-a mRNA compared to wild-type cells. In a similar experimental design, Moore et al. 14 also reported activation of TNF expression in the ES-differentiated macrophages after LPS stimulation. It should be emphasized that ES cells used in gene targeting are heterozygous for the targeted gene and only one copy of the given gene is missing whereas the other is fully functioning. Therefore, the LITAF effect on TNF-a expression observed in our ES cell experiments results from the inactivation of only one copy of LITAF. It is conceivable that TNF levels would be substantially affected in ES cells homozygous for LITAF but probably not completely abrogated suggesting that other transcription factors may act in concert with LITAF to regulate LPSinduced TNF-a gene expression. These data strongly suggest that the LITAF gene product plays an important 22 Bolcato-Bellemin, Mattei, Fenton, Amar Fig. 6 . TNF-a expression in LITAF-deficient macrophages (representative of 3 independent experiments). Wild-type (WS) and LITAF heterozygous (LS) ES cells (see Materials and Methods) were cultured and differentiated into the macrophages lineage. After 2.5 h LPS stimulation, total RNA was extracted and subjected to RT-PCR. TNF-a expression was quantified by densitometric analysis using a gel documentation system. Expression of bactin was used as internal control for quantification. Note that LITAFdeficient macrophages expressed 35% less TNF-a.
Fig. 5.
Increase of LITAF transcript level after LPS stimulation (representative of 3 independent experiments). The cells (2 x 10 6 ) were cultured in two conditions -untreated or stimulated by E. coli LPS (100 ng/ml) for 4 h. The RNA was recovered from the cells and submitted to Northern blot analysis as described in Materials and Methods. After stripping of mouse LITAF coding region probe, the blot was rehybridized with a G3PDH probe for control and quantification. Expression of LITAF mRNA transcripts was quantified using the Kodak Digital Science 1D Software. Note that LPS stimulated a 2-fold increase of LITAF mRNA as compared to untreated cells. role in the regulation of TNF-a and substantiate the at least partial role of mouse LITAF in mouse organogenesis. The scope of our functional study is not broad enough for us to rule out the possibility that exogenous LITAF gene products may regulate TNF-a gene expression in other ways than what occurs naturally. We propose three possibilities for how the LITAF gene product may regulate TNF-a gene expression: (i) the LITAF gene product is sufficient to activate TNF-a gene expression by itself; (ii) the LITAF protein may have to be processed to be able to activate the TNF-a gene; and/or (iii) the LITAF gene product may require a co-factor to activate TNF-a. Nonetheless, the present results support other data suggesting that LPS induction of the TNF-a promoter may be mediated by the concerted participation of at least two separate, cis-acting regulatory elements. 19 
CONCLUSIONS
Together, the present data suggest that mouse LITAF gene plays a crucial role in the control of TNF-a gene expression as previously demonstrated in humans 11, 21 and suggest a potential role of LITAF in mouse organogenesis. We have recently shown in humans that LITAF is able to bind the TNF-a promoter. 21 These data suggest a role for LITAF in organogenesis indirectly via TNF-a. However, we cannot rule out the possibility of a direct action of LITAF on mouse organogenesis.
